Daniel Trapini

Daniel Trapini is a Marketing Professional currently serving as the Director of Global Oncology Precision Medicine Marketing at Merck, where they incorporate commercial strategy during the pre-launch development of companion diagnostics. With a career spanning from 2004 to the present, they have held various marketing positions focusing on HCP strategy and have a significant background in hospital sales. Daniel recently completed an international marketing assignment in Ireland, working on PD-L1 Biomarker testing for KEYTRUDA. They hold an MBA in Marketing from Fordham Gabelli School of Business and a BS in Management Science & Information Systems from Penn State University.